H.C. Wainwright downgraded MacroGenics to Neutral from Buy with a price target of $14, up from $12. The analyst cites valuation for the downgrade following the stock’s recent rally.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MGNX:
- MacroGenics to Participate in Upcoming Investor Conference
- Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
- MacroGenics price target raised to $16 from $10 at JMP Securities
- Biotech Alert: Searches spiking for these stocks today
- MacroGenics upgraded to Buy at Citi on accelerating momentum in ADC space
